Cargando…
A comparative effectiveness analysis of the PBCG vs. PCPT risks calculators in a multi-ethnic cohort
BACKGROUND: Predictive models that take race into account like the Prostate Cancer Prevention Trial Risk Calculator 2.0 (PCPT RC) and the new Prostate Biopsy Collaborative Group (PBCG) RC have been developed to equitably mitigate the overdiagnosis of prostate specific antigen (PSA) screening. Few st...
Autores principales: | Carbunaru, Samuel, Nettey, Oluwarotimi S., Gogana, Pooja, Helenowski, Irene B., Jovanovic, Borko, Ruden, Maria, Hollowell, Courtney M. P., Sharifi, Roohollah, Kittles, Rick A., Schaeffer, Edward, Gann, Peter, Murphy, Adam B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6880480/ https://www.ncbi.nlm.nih.gov/pubmed/31771578 http://dx.doi.org/10.1186/s12894-019-0553-6 |
Ejemplares similares
-
Does Prostate Volume Correlate with Vitamin D Deficiency Among Men Undergoing Prostate Biopsy?
por: Murphy, Adam B., et al.
Publicado: (2016) -
Performance of prostate health index and PSA density in a diverse biopsy‐naïve cohort with mpMRI for detecting significant prostate cancer
por: Carbunaru, Samuel, et al.
Publicado: (2021) -
A prostate biopsy risk calculator based on MRI: development and comparison of the Prospective Loyola University multiparametric MRI (PLUM) and Prostate Biopsy Collaborative Group (PBCG) risk calculators
por: Patel, Hiten D., et al.
Publicado: (2022) -
Germline genetic variation in prostate susceptibility does not predict outcomes in the chemoprevention trials PCPT and SELECT
por: Ahmed, Mahbubl, et al.
Publicado: (2019) -
Observational study comparing the accuracy/variability between the ERSPC and the PCPT risk calculators for the prediction of significant prostate cancer in patients with PSA <10 ng/mL
por: Gomez Gomez, Enrique, et al.
Publicado: (2019)